We are live on
!
Find out more
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
78 hedge funds and large institutions have $74.4M invested in Synergy Pharmaceuticals, Inc Common Stock in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 30 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
48% more call options, than puts
Call options by funds: $319K | Put options by funds: $216K
9% less funds holding
Funds holding: 86 → 78 (-8)
23% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 30
37% less capital invested
Capital invested by funds: $118M → $74.4M (-$43.6M)
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Holders
78
Holders Change
-8
Holders Change %
-9.3%
% of All Funds
2.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
23
Reduced
30
Closed
13
Calls
$319K
Puts
$216K
Net Calls
+$103K
Net Calls Change
+$5.93M
Top Buyers
| 1 |
CI
Cowen Inc
New York
|
+$653K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$539K |
| 3 |
Goldman Sachs
New York
|
+$404K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$402K |
| 5 |
Bank of New York Mellon
New York
|
+$334K |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$3.65M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$2.85M |
| 3 |
HCM
Highbridge Capital Management
New York
|
-$997K |
| 4 |
Millennium Management
New York
|
-$885K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$881K |
